Concomitant Versus Hybrid Regimen for H. Pylori Eradication

PHASE4CompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

February 21, 2018

Primary Completion Date

October 21, 2020

Study Completion Date

January 31, 2021

Conditions
H.Pylori InfectionH.Pylori Gastrointestinal DiseaseH. Pylori Associated Phlegmonous Gastritis
Interventions
DRUG

10 day concomitant regimen

10 Day Concomitant Hp therapy Concomitant for 10 days, including 40 mg of esomeprazole bid, amoxicillin 1g bid, clarithromycin 500mg bid and metronidazole 500mg bid

DRUG

14 day hybrid regimen

14 Day Hybrid Hp therapy Hybrid for 14 days, including 40 mg of esomeprazole bid and amoxicillin 1g bid, for the first 7 days followed by esomeprazole 40mg bid, amoxicillin 1g bid, clarithromycin 500mg bid and metronidazole 500mg bid, for another 7 days.

Trial Locations (1)

11528

Alexandra General Hospital, Athens

All Listed Sponsors
collaborator

Hellenic Society of Gastroenterology

UNKNOWN

lead

Alexandra Hospital, Athens, Greece

OTHER

NCT03592069 - Concomitant Versus Hybrid Regimen for H. Pylori Eradication | Biotech Hunter | Biotech Hunter